In our study, chemotherapy-induced muscle atrophy was observed along with the upregulation of atrogin-1 in PMM, which was consistent with the results of previous studies [21,29], while upregulation of MuRF-1 was not seen. This evidence concerns the gene FBXO32 and Atrophy.